Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2008 / Cilt: 34 - Sayı: 1

Primary bladder lymphoma: a case report with PET-CT findings

Mesanenin primer lenfoması: PET-BT bulgularıyla birlikte olgu sunumu

Pages
133–135
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we report a case with primary bladder lymhoma confirmed after pathological investigation, which operated in our department with the diagnosis of bladder cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Non hodgkin’s lymphoma (NHL) is classified as nodal and extranodal lymphoma according to their primary site of origin.
📊
Key Findings & Data:The incidence of extranodal lymphoma varies between 24-48% in different series.
💡
Conclusion & Impact:In this article, we report a case with primary bladder lymhoma confirmed after pathological investigation, which operated in our department with the diagnosis of bladder cancer.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Lenfom · Hodgkin dışı · Dizüri

Abstract

Non hodgkin’s lymphoma (NHL) is classified as nodal and extranodal lymphoma according to their primary site of origin. The incidence of extranodal lymphoma varies between 24-48% in different series. The most common site of extranodal lymphoma was gastrointestinal system (44.6%). Primary bladder lymphoma is a very rare condition, which consisted for only 0.2% of extranodal lymphoma. The articles about for this subject generally are given as case reports. In this article, we report a case with primary bladder lymhoma confirmed after pathological investigation, which operated in our department with the diagnosis of bladder cancer.

Özet

Hodgkin dışı lenfoma (NHL)’lar yerleşimlerine göre genel olarak nodal ve extranodal yerleşimli olarak gruplandırılmaktadır. Ekstranodal tutulum değişik serilerde farklı oranlarda (%22-48) bulunmaktadır. Ekstranodal tutulumun en sık gözlendiği anatomik yerleşim gastrointestinal sistemdir (%44.6). Primer mesane lenfoması ise, çok ender görülmekle birlikte extranodal lenfomaların %0.2’ni oluşturmaktadır. Bu konuyla ilgili yayınlar daha çok olgu sunumu şeklinde bildirilmektedir. Bu yazıda, mesane tümörü ön tanısıyla kliniğimizde ameliyat edilen ve patolojik inceleme sonrası primer mesane lenfoması tespit edilen bir olgu sunulmaktadır.

🔖

Cite This Article

SEÇKİNER, İ., ERTURHAN, M. S., ÇELİK, M., ERBAĞCI, A., YAĞCI, F. (2008). Primary bladder lymphoma: a case report with PET-CT findings. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 34 - Sayı: 1, 133–135. https://ajindex.com/articles/328718

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Arıcan A: Primer Extranodal Lenfomalar. Hematoloji- Onkoloji Güncel Derleme Dergisi; 2: 273-84, 2000
  2. Dinçol H: Hodgkin dışı lenfomalara bakış. Hematoloji- Onkoloji Güncel Derleme Dergisi; 2: 268-72, 2000
  3. Freeman C, Berg JW: Occurrence and prognosis of ext- ranodal lymphomas. Cancer; 29: 252-60, 1972
  4. National Cancer Institute sponsored study of classifi- cations of non-hodgkin’s lymphomas: Summary and description of a working formulation for clinical usage. Cancer; 49: 2112-35, 1982
  5. Simpson RHW, Bridger JE, Anthony PP, et al: Malig- nant lymphoma of the lower urinary tract: A clinicopat- hologic study with review of literature. Br J Urol; 65: 254-60, 1990
  6. Bates AW, Norton AJ, Baithun SI: Malignant lympho- ma of the urinary bladder: A clinicopathological study of 11 cases. J Clin Pathol; 53: 458-61, 2000
  7. Al-Maghrabi J, Kamel Reid S, Jewett M, et al: Prima- ry low grade B-cell lymphoma of mucosa-associated lymphoid tissue type (MALT). Arch Pathol Lab Med; 125: 332-36, 2001
  8. Hughes M, Morrison A, Jackson R: Primary bladder lymphoma: Management and outcome of 12 patients with a review of the literature. Leuk Lymphoma; 46: 873-77, 2005
  9. Paul R: Comparison of fluorine-18-2-fluorodeoxygluco- se and gallium-67 citrate imaging for detection of lymp- homa, J Nucl Med; 28: 288-292, 1987
  10. Specht L: 2-[18F]fluoro-2-deoxyglucose positron-emis- sion tomography in staging, response evaluation and tre- atment planning of lymphomas. Semin Radiat Oncol; 17: 190-197, 2007
  11. Elstrom R, Guan L, Baker G: Utility of FDG-PET scanning in lymphoma by WHO classification, Blood; 101: 3875-3876, 2003.